ZNF460 binds to prediction sites in the CD24 promoter region, and ZNF460 leads to significant induction of CD24 promoter activity, so the up-regulation of CD24 in BC is due in part to CD24 activation during tumor progression. Here, ZNF460 is linked to breast cancer.